Deprecated: Creation of dynamic property Penci_AMP_Post_Template::$ID is deprecated in /home/u444474283/domains/gwcmag.com/public_html/wp-content/plugins/penci-soledad-amp/includes/class-amp-post-template.php on line 46

Deprecated: Creation of dynamic property Penci_AMP_Post_Template::$post is deprecated in /home/u444474283/domains/gwcmag.com/public_html/wp-content/plugins/penci-soledad-amp/includes/class-amp-post-template.php on line 47
US FDA Approves First Drug For Fatty Liver Disease NASH - GWC Mag - Your Trusted Source For Green Technology, Sustainability, And Environmental Innovation US FDA Approves First Drug For Fatty Liver Disease NASH - GWC Mag - Your Trusted Source For Green Technology, Sustainability, And Environmental Innovation
Green Health & Wellness

US FDA approves first drug for fatty liver disease NASH – GWC Mag

gwcmag052 views

Health

14 March 2024, 2:54 pm 1 minute

Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind. 

Market Impact

The company’s shares surged 24% in extended trading.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Americas

Countries: United States

Win Types: Speed

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Related posts

Gossiping can benefit mental health, but also presents risks, experts say – GWC Mag

Johnson & Johnson (JNJ) earnings Q1 2024 – GWC Mag

UnitedHealth says Change Healthcare cyberattack cost it $872 million – GWC Mag

Add Comment